A recent post in the April/ May Issue of MIT Review discusses the science Uzma Samadani used as she sought to find a way to measure improvements in her severely, brain-injured patients. The ability to capture a large amount of data from tracking not only eye movement but restrictions on range of motion in the eye led to the EyeBox product being developed by Oculogica, one of Sofia Fund’s portfolio companies. Eye tracking has been used for centuries but measuring and interpreting the restrictions on the range of motion without a baseline measurement is helping take the guesswork out of diagnosing and tracking improvements in concussed patients. See more at Looking Concussion in the Eye
Older post: Sofia Fund Invests in Joylux, Inc
Newer post: Sofia Fund Focus on Women-Led Firms